| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $163.0M | +37.6% |
| SG&A Expense | $66.9M | +101.2% |
| Operating Income | -$230.0M | -51.5% |
| Interest Expense | $208K | -93.4% |
| Net Income | -$209.4M | -40.2% |
| EPS (Basic) | -$2.98 | -21.1% |
| EPS (Diluted) | -$2.98 | -21.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $295.4M | +297.3% |
| Short-term Investments | $275.3M | -31.4% |
| Current Assets | $580.9M | +18.6% |
| Total Assets | $612.9M | +23.3% |
| Current Liabilities | $58.1M | +99.9% |
| Total Liabilities | $58.7M | +97.0% |
| Stockholders' Equity | $554.2M | +18.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$160.6M | -20.1% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $117.6M | +163.2% |
| Financing Cash Flow | $264.1M | +53.3% |
| Free Cash Flow | -$160.6M | -20.1% |